First‐in‐human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors

TAS0313, a novel cancer vaccine cocktail, was developed to overcome the disadvantages of previously developed short and long peptide vaccines; it comprises several long peptides targeting multiple cancer antigens. We evaluated TAS0313 monotherapy in Japanese patients with advanced solid tumors for w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Kondo, Shunsuke, Shimizu, Toshio, Koyama, Takafumi, Sato, Jun, Iwasa, Satoru, Yonemori, Kan, Fujiwara, Yutaka, Shimomura, Akihiko, Kitano, Shigehisa, Tamura, Kenji, Yamamoto, Noboru
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
ORIGINAL ARTICLES
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019195/
https://ncbi.nlm.nih.gov/pubmed/33615628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados